We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

UPS Makes Enhancements to Support Medical Device Industry

By HospiMedica International staff writers
Posted on 30 Jul 2014
UPS (Atlanta, GA, USA) has announced it has developed a healthcare-compliant network of field stocking locations (FSLs) to reduce delivery time of medical device shipments and enhance inventory visibility.

The network includes 36 healthcare-capable FSLs strategically located to support time-sensitive distribution and efficient warehousing of products, providing access to over 80% of US hospital beds within four hours. The facilities will operate under guidance of the UPS quality assurance and compliance program, and will feature temperature-controlled environments and same-day delivery services. These features will enable medical device manufacturers and field sales representatives to provide best-in-class service to their customers and better manage their inventories.

The planned network marks the latest in a series of recent expansions to UPS's healthcare compliant network, which in addition to the 36 FSLs also includes 46 healthcare dedicated and compliant warehousing and distribution facilities worldwide, as well as a full suite of UPS temperature-sensitive transportation and risk mitigation solutions. The UPS healthcare facilities also help manufacturers ensure regulatory compliance, protect high-value and temperature-sensitive products, and speed distribution to end providers.

“Due to an increasingly complex regulatory environment and significant cost pressures, medical device manufacturers are looking to the supply chain to lower costs through inventory reduction and enhanced visibility,” said John Menna, vice president of global healthcare strategy at UPS. “Based on our experience in healthcare distribution and utilizing UPS's industry-leading global FSL network, we have created a tailored inventory management and distribution solution to meet the unique needs of medical device manufacturers.”

The UPS FSL network includes more than 950 locations globally, and has been in operation since 1995. The network is utilized by multiple industries including high-tech, telecommunications, and aerospace, industrial, automotive, and nonregulated medical device manufacturers.

Related Links:

UPS


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
Blood Gas Analyzer
i-Check200
Radiofrequency Generator
GX1
Tourniquet System
heidi– mein Tourniquet

Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more